Supraventricular Arrhythmias AAT.A FLUTTER.A FIB

Slides:



Advertisements
Similar presentations
Cardiovascular 2 Phase 2 Michelle Mair
Advertisements

The electrocardiogram (ECG or EKG)
Supraventricular Tachycardia in Infancy and Childhood
Management of Supraventricular Tachycardias
Approach to narrow QRS tachycardia.  The normal RMP in myocardium is -90 mv  SA node differs from myocardium by  RMP is -65 mv  low overshoot  short.
ATRIAL FIBRILLATION Linda A. Snyder, MSN, CRNP. Definition: A common arrhythmia characterized by chaotic, rapid, discontinuous atrial depolarizations.
ECG Rhythm Interpretation
Bradycardia and Narrow Complex Tachycardia
Supraventricular Tachycardia: Making the diagnosis
Cardiovascular course 4th year - Pathophysiology
Mechanism of Arrhythmia Fellow School Lecture Series Mahmoud Houmsse, MD. July 11 th, 2014.
Atrial Flutter Chris Caulfield AM Report 2/19/10.
Arrhythmias: The Good, the Bad and the Ugly
SUPRAVENTRICULAR TACHYCARDIA
Jay Green Emergency Medicine Resident, PGY-3 July 24, 2008.
Arrhythmias Principles of long and short term management of arrythmias.
Pediatric Dysrhythmias Board Review
Arrhythmia recognition and treatment
Junctional Rhythms / A-V Nodal Rhythm. Aims and Objectives.  Investigate common types of Junctional and AV nodal tachycardias.  Understand underlying.
Sinus, Atrial, Junctional / Nodal, Ventricular, Blocks, others.
Junctional Dysrhythmias
Natalia Fernandez, PT, MS, MSc, CCS University of Michigan Health Care System Department of Physical Medicine and Rehabilitation.
Electrocardiogram Primer (EKG-ECG)
Fast & Easy ECGs, 2nd E – A Self-Paced Learning Program
Supraventricular Tachycardia: Mechanisms, Diagnosis, & Management
Cardiac Electrophysiology & Ablation
ARRHYTHMIAS.
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
DIAGNOSING & TREATING PALPITATIONS
Supraventricular Arrhythmias
Supraventricular Arrhythmias Claire B. Hunter, M.D.
Leonard Steinberg, MD Timothy Knilans, MD The Heart Center Children’s Hospital Medical Center Cincinnati, OH The diagnosis and management of supraventricular.
EKG Interpretation: Arrhythmias Humayun J. Chaudhry, D.O., FACP, FACOI Assistant Dean for Pre-Clinical Education and Chairman, Department of Medicine N.Y.
Department faculty and hospital therapy of medical faculty and department internal diseases of medical prophylactic faculty. Cardiac arrhythmia Docent.
Fast & Easy ECGs – A Self-Paced Learning Program
SupraVentricular Tachycardia (SVT)
EKG Interpretation: Arrhythmias Mustafa Salehmohamed, D.O. Assistant Clinical Instructor Department of Medicine N.Y. College of Osteopathic Medicine October.
DIAGNOSIS OF CARDIAC RHYTHMS
September 23, 2010 Morning Report. ECG Rate Rhythm What do you think? What do you want to do?
By Dr. Zahoor CARDIAC ARRHYTHMIA.
BIMM118 Cardiac Arrhythmia Arrhythmias : Abnormal rhythms of the heart that cause the heart to pump less effectively Arrhythmia occurs: –when the heart’s.
Morning report ECG Elias B Hanna, MD LSU New Orleans, Cardiology.
Tachyarrhythmia Gaurav Panchal. Arrhythmogenesis Impulse formation –Automaticity – inappropriate Tachy / brady; accelerated Ventricular rate after MI.
Clk. Alexander L. Gonzales II December 14, SINUS RHYTHM  >60bpm and
Normal EKG – P wave: Atrial depolarization – PR interval: < 0.20 sec – QRS complex: ventricular depolarization – QRS interval < 0.10 sec SA 0.10 – 0.12.
ECG intereptation Abdualrahman ALshehri Lecturer King Saud University
EP Sale’s Training Summary.
MECHANISMS OF CARDIAC ARRHYTHMIAS. DR AMNA TAHIR PHYSIOLOGY DEPARTMENT. KEMU.
Arrhythmias An arrhythmia is… – disturbance of the electrical rhythm of the heart. Classification – Supraventicular (sinus, atrial, junctional) and..
ARRHYTHMIA Objectives At the end of this session students should be able to:  Distinguish the normal from abnormal rhythms.  Understand the pathophysiologic.
Approach to Arrhythmias Armed Forces Academy of Medical Sciences.
The Diagnosis and Management of Cardiac Dysrhythmias - Atrial tachycardia. Pharmacologic treatment 8/19/09.
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC guidelines for the management of patients.
IN THE NAME OFGODIN THE NAME OFGOD SVTS.SAYAH.  All cardiac tachyarrhythmias are produced by: 1/disorders of impulse initiation :automatic 2/abnormalities.
ARRHYTHMIAS Jamil Mayet. Arrhythmias - learning objectives –Mechanisms of action of antiarrhythmic drugs –Diagnosis To differentiate the different types.
H. Barakpour,MD.,Electrophysiologist November 2014,Javad-Alaeme Heart Hospital.
Cardiac Arrhythmias An Introduction: Dr.S.Nandakumar.
Arrhythmias and EKGs.
With 2 : 1 conduction, the ventricular rate is approximately 150 beats/min, often making flutter waves themselves difficult to appreciate and allowing.
Supra Ventricular Tachycardia (SVT)
David Sanders Mini-Lecture 2017
When Catheter Ablation Should Be First Line Therapy
Chapter 4 Atrial Rhythms.
ARRHYTHMIA DR MANSOUR ALQURASHI
Management of Atrial Fibrillation
Narrow complex tachycardia
ECG Case #1 Scott E. Ewing, DO.
تهيه كننده : علي اكبر اكبر پور سوپروایزر آموزشی – دبیر طرح تحول سلامت
ECG Lecture Scott Ewing, D.O. April 5, 2005.
Presentation transcript:

Supraventricular Arrhythmias AAT.A FLUTTER.A FIB MEHDI BAKHSHI MSN PhD ICNS

Definition Rapid heart rhythm during which the electrical impulse propagates down the normal His Purkinje system similar to normal sinus rhythm Distinct from ventricular tachycardia which only originates in the ventricles

Mechanisms of Arrhythmia Automaticity Enhanced automaticity Abnormal automaticity

Mechanisms of Arrhythmia Triggered Activity Small depolarizations during or just after repolarization (phases 3 or 4) which can trigger a new depolarization.

Mechanisms of Arrhythmia Reentry-most common mechanism Short circuit that forms between two “pathways” that are either anatomically or functionally distinct Typically: Path 1: Slow conduction, short refractory period Path 2: Rapid conduction, long refractory period

Reentry Panel A: Most impulses conduct down both pathways. Panel B: Unidirectional block, due to longer refractoriness in one pathway. Panel C: Potential to have reentry back up the previously refractory pathway Panel D: Reentry then can persist.

Supraventricular Arrhythmias Atrial arrhythmias (AT, AFL and AF) Atrioventricular nodal reentrant tachycardia (AVNRT) and junctional ectopic tachycardia (JET) Atrioventricular reentrant tachycardia (AVRT) Wolf-Parkinson-White Syndrome Orthodromic AVRT Antidromic AVRT

SVT: Symptoms May be variable Palpitations, chest pounding, neck pounding Weakness/malaise Dyspnea Chest pain Lightheadedness Near syncope/syncope Symptoms usually abrupt in onset and termination May have history of symptoms since childhood or have a positive FHx

SVT: Physical Exam In absence of tachycardia, usually normal Rapid heart rate (150-250) May be irregular or regular (mechanism) BP may be low or with narrow pulse pressure Neck veins may reveal cannon waves.

Supraventricular Arrhythmias Atrial arrhythmias (AT, AFL and AF) Atrioventricular nodal reentrant tachycardia (AVNRT) and junctional ectopic tachycardia (JET) Atrioventricular reentrant tachycardia (AVRT) Wolf-Parkinson-White Syndrome Orthodromic AVRT Antidromic AVRT

Sinus Rhythm Originates in sinus node (automaticity) 50-100 bpm resting Up to 200 bpm Conduction through normal AV axis P wave morphology reflects site of onset

Atrial Tachycardia Ectopic atrial focus 150-250 bpm 1:1 AV conduction Reentrant, automatic or triggered 150-250 bpm 1:1 AV conduction Paroxysmal or “warm up” P wave morphology variable

Focal Atrial Tachycardia CSO IVC RAFW RAA LAA LAFW PV SN I A S CT * * * SVC

20 yr woman with post-partum congestive heart failure II III aVR aVL aVF V1 V2 V3 V4 V5 V6

Adenosine Injection I II III aVR aVL aVF V1 V2 V3 V4 V5 V6

Atrial Flutter Reentrant circuit localized to the RA 250-350 bpm 2:1 or variable AV block Classic “saw-tooth” P waves

Activation on Halo Catheter Typical = Counterclockwise V1 II aVF TA 19,20 TA 1,2 TA 9,10 TA 3,4 TA 5,6 TA 7,8 CS Os TA 9,10 TA 1,2 TA 11,12 TA 13,14 TA 17,18 TA 19,20 CS Os

Activation on Halo Catheter Atypical = Clockwise II aVF V1 CS Os TA 1,2 TA 3,4 TA 5,6 TA 7,8 TA 9,10 TA 11,12 TA 13,14 TA 17,18 19,20 TA 19,20 TA 9,10 CS Os TA 1,2

Atrial Fibrillation Chaotic atrial rhythm due to multiple reentrant wavelets 350-500 bpm Ventricular rate irregular and rapid due to variable AV block HTN, valvular dz., metabolic dz., CMP,

Atrial Fibrillation The rapid atrial activity results in: Increased risk of thrombus formation and stroke Rapid and irregular ventricular rate The treatment is aimed at: Decreasing the risk of stroke (coumadin, ASA) Decreasing the ventricular rate (beta-blockers, calcium channel blockers, digoxin) Restoring the rhythm to sinus (drug therapy, catheter ablation, surgical Maze)

Atrial Fibrillation Advantages of rhythm control: Abolition of symptoms Halting atrial enlargement Improvement in left ventricular function and exercise capacity Disadvantages of rhythm control: Subjecting patients to drug therapy and/or procedure that might be associated with complications

Atrial Fibrillation Treatment In patients with minimal symptoms and normal left ventricular function: Coumadin/ASA Rate control (drugs, AVJ ablation + BV pacing) In patients with significant symptoms and/or left ventricular dysfunction: Rhythm control (anti-arrhytmic drugs, catheter ablation)

Drug Therapy to Maintain Sinus Rhythm in Patients with Recurrent Paroxysmal or Persistent Atrial Fibrillation ACC/AHA/ESC Guidelines Heart Disease No (or minimal) Yes Heart Failure CAD Hypertension Flecainide Propafenone Sotalol LVH greater than or equal to 1.4 cm Amiodarone Dofetilide Sotalol Amiodarone Dofetilide Amiodarone, Dofetilide Yes No The recommendations for drug therapy for patients with recurrent paroxysmal or persistent AF are presented in this slide. For patients with no (or minimal) heart disease, therapy should begin with flecainide, propafenone, or sotalol. If these drugs do not prove to be effective, amiodarone or dofetilide may be initiated. If AF persists, treatment with disopyramide, procainamide, or quinidine may be attempted. Nonpharmacological options may also be considered at this point. The presence of heart disease incurs a higher risk of adverse events with the use of antiarrhythmic agents and therapy must be tailored to the type of heart disease present and data in the medical literature regarding safety. For patients with heart failure, amiodarone and dofetilide are the drugs of choice. For patients with CAD, a first attempt should be made using sotalol, followed by amiodarone and dofetilide. Disopyramide, procainamide, or quinidine may be used in these patients if the more appropriate drugs fail. Hypertensive patients with LVH 1.4 cm can be treated with amiodarone. The first choice for hypertensive patients with LVH <1.4 cm is flecainide, propafenone, followed by amiodarone, dofetilide or sotalol. If AF persists, these patients can be treated with disopyramide, procainamide or quinidine. Flecainide Propafenone Disopyramide Procainamide Quinidine Disopyramide Procainamide Quinidine Consider nonpharmacological options Amiodarone Dofetilide Sotalol Amiodarone Fuster et al. J Am Coll Cardiol. 2001;38:1231-1265. Disopyramide, Procainamide, Quinidine Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation.) J Am Coll Cardiol. 2001;38:1231-1265.

Atrial Fibrillation Catheter Ablation Ablate PV potentials PV Isolation Pappone (circumferential LA ablation)

Supraventricular Arrhythmias Atrial arrhythmias (AT, AFL and AF) Atrioventricular nodal reentrant tachycardia (AVNRT) and junctional ectopic tachycardia (JET) Wolf-Parkinson-White Syndrome Orthodromic AVRT Antidromic AVRT Atrial fibrillation with preexcitation

AV Nodal Reentrant Tachycardia Morphology and location of P wave relative to QRS distinct

27 y.o with palpitations Does seeing the next ECG help you

Pseudo R’ in V1 during tachycardia NSR AVNRT

Junctional Ectopic Tachycardia

Normal sinus rhythm Junctional tachycardia

Supraventricular Arrhythmias Atrial arrhythmias (AT, AFL and AF) Atrioventricular nodal reentrant tachycardia (AVNRT) and junctional ectopic tachycardia (JET) Atrioventricular reentrant tachycardia (AVRT) Wolf-Parkinson-White Syndrome Orthodromic AVRT Antidromic AVRT

Wolff-Parkinson-White Syndrome Second electrical connection exists between the atria and ventricles (accessory pathway) Resemble atrial tissue Results in a short PR and Delta wave (pre-excitation) Some AP conducts only retrograde (concealed)

Arrythmias in WPW The most common arrhythmia is orthodromic AV reentrant tachycardia (narrow QRS) Less common are pre-excited tachcyardias (wide QRS) Antidromic AV reentrant tachycardia Atrial tachycardia/flutter with pre-excitation AVNRT with pre-excitation Atrial fibrillation with pre-excitation (most life threatening due to rapid ventricular response)

Orthodromic AVRT Conduction down AV axis during tachycardia gives NARROW QRS complex

Pre-excited Tachycardia Mechanisms AT AVRT AVNRT Conduction down AP during tachycardia gives WIDE QRS complex

Atrial Fibrillation

RF Ablation in WPW

Supraventricular Arrhythmias Atrial arrhythmias (AT, AFL and AF) Atrioventricular nodal reentrant tachycardia (AVNRT) and junctional ectopic tachycardia (JET) Atrioventricular reentrant tachycardia (AVRT) Wolf-Parkinson-White Syndrome Orthodromic AVRT Antidromic AVRT

SUMMARY Mechanisms of SVT Atrial Tachycardia AVNRT AVRT SP FP Predictions about V:A time for DDX Circuits require two pathways with different conduction vel and different refractory periods Atrial Tachycardia AVNRT AVRT

Differential Diagnosis of NCT Short RP AVRT AT Slow-Slow AVNRT Long RP AT Atypical AVNRT PJRT P buried in QRS Typical AVNRT AT JET

SUMMARY Obtain a 12 lead ECG. The location of the P wave will dictate the differential diagnosis If hemodynamically unstable (chest pain, heart failure, hypotension) CARDIOVERSION If hemodynamically stable AV NODAL AGENT Long term therapy depends on mechanism and can be conservative, pharmacologic or invasive EP study often needed for definitive characterization of mechanism and can cure most SVTs with 90% success rate